These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9854983)

  • 41. Novel GCH1 mutation in a Brazilian family with dopa-responsive dystonia.
    Camargos ST; Cardoso F; Momeni P; Gianetti JG; Lees A; Hardy J; Singleton A
    Mov Disord; 2008 Jan; 23(2):299-302. PubMed ID: 18044725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical analysis of dopa-responsive dystonia and mutation analysis of the GCH I gene].
    Xie H; Wu ZY; Wang N; Li ZW; Lin MT; Murong SX
    Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):492-5. PubMed ID: 17044972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Segawa disease with a novel heterozygous mutation in exon 5 of the GCH-1 gene (E183K).
    Ikeda T; Kanmura K; Kodama Y; Sawada K; Nunoi H; Hasegawa K
    Brain Dev; 2009 Feb; 31(2):173-5. PubMed ID: 18621497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?
    Tassin J; Dürr A; Bonnet AM; Gil R; Vidailhet M; Lücking CB; Goas JY; Durif F; Abada M; Echenne B; Motte J; Lagueny A; Lacomblez L; Jedynak P; Bartholomé B; Agid Y; Brice A
    Brain; 2000 Jun; 123 ( Pt 6)():1112-21. PubMed ID: 10825351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopa-responsive dystonia.
    Nygaard TG
    Curr Opin Neurol; 1995 Aug; 8(4):310-3. PubMed ID: 7582048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroleptic malignant syndrome with prolonged catatonia in a dopa-responsive dystonia patient.
    Ihara M; Kohara N; Urano F; Ichinose H; Takao S; Nishida T; Saiki H; Kawamoto Y; Ikeda A; Takagi S; Shibasaki H
    Neurology; 2002 Oct; 59(7):1102-4. PubMed ID: 12370475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tardive dyskinesia in dopa-responsive dystonia: a reappraisal of the dopamine hypothesis of tardive dyskinesia.
    de la Fuente-Fernández R
    Neurology; 1998 Apr; 50(4):1134-5. PubMed ID: 9566407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GTP cyclohydrolase I gene, dystonia, juvenile parkinsonism, and Parkinson's disease.
    Nagatsu T; Ichinose H
    J Neural Transm Suppl; 1997; 49():203-9. PubMed ID: 9266429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two in the hand, an essential lesson in tremor management.
    Gallagher P; Archibald N; Goldsmith P; Burn D
    Pract Neurol; 2010 Jun; 10(3):160-3. PubMed ID: 20498189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mutation analysis of GCH1 gene in Chinese patients with dopa responsive dystonia].
    Li J; Tang BS; Guo JF; Zhang YH; Xie ZG; Yan XX; Shen L; Jiang H; Zhang XW; Xia K; Pan Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):302-4. PubMed ID: 17557242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopa-responsive dystonia presenting as delayed and awkward gait.
    Cheyette BN; Cheyette SN; Cusmano-Ozog K; Enns GM
    Pediatr Neurol; 2008 Apr; 38(4):273-5. PubMed ID: 18358407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hereditary progressive dystonia with marked diurnal fluctuation--clinical features and GTP cyclohydrolase I gene mutations].
    Tamaru Y; Ito H; Imai T; Hirano M; Ueno S
    Nihon Rinsho; 1997 Jan; 55(1):135-8. PubMed ID: 9014437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dominant negative effect of GTP cyclohydrolase I mutations in dopa-responsive hereditary progressive dystonia.
    Hirano M; Yanagihara T; Ueno S
    Ann Neurol; 1998 Sep; 44(3):365-71. PubMed ID: 9749603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two previously unrecognized splicing mutations of GCH1 in Dopa-responsive dystonia: exon skipping and one base insertion.
    Weber Y; Steinberger D; Deuschl G; Benecke R; Müller U
    Neurogenetics; 1997 Sep; 1(2):125-7. PubMed ID: 10732814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopamine deficiency.
    Jeon BS; Jeong JM; Park SS; Lee MC
    Adv Neurol; 1998; 78():309-17. PubMed ID: 9750927
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of GTP cyclohydrolase-1 on tyrosine hydroxylase expression: implications in DOPA-responsive dystonia.
    Kang UJ; Bencsics C; Wachtel S; Lew R
    Adv Neurol; 1998; 78():319-24. PubMed ID: 9750928
    [No Abstract]   [Full Text] [Related]  

  • 57. Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency.
    Furukawa Y; Kish SJ; Fahn S
    Ann Neurol; 2004 Jan; 55(1):147-8. PubMed ID: 14705130
    [No Abstract]   [Full Text] [Related]  

  • 58. Dopa-responsive dystonia: recent advances and remaining issues to be addressed.
    Furukawa Y; Kish SJ
    Mov Disord; 1999 Sep; 14(5):709-15. PubMed ID: 10495030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel mutation in GCH-1 gene in a case of dopa-responsive dystonia.
    De Rosa A; Carducci C; Antonozzi I; Giovanniello T; Xhoxhi E; Criscuolo C; Menchise V; Striano S; Filla A; De Michele G
    J Neurol; 2007 Aug; 254(8):1133-4. PubMed ID: 17410324
    [No Abstract]   [Full Text] [Related]  

  • 60. An intragenic duplication in guanosine triphosphate cyclohydrolase-1 gene in a dopa-responsive dystonia family.
    Ling H; Polke JM; Sweeney MG; Haworth A; Sandford CA; Heales SJ; Wood NW; Davis MB; Lees AJ
    Mov Disord; 2011 Apr; 26(5):905-9. PubMed ID: 21287604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.